Effect of Salmeterol on Allergen- Induced Airway Inflammation in Mild Allergic Asthma

نویسنده

  • Mary Beth Bollinger
چکیده

then done with either placebo (n 21) or salmeterol 42 g twice daily (n 154) for 2 weeks at stable doses. Next was an ICS reduction phase over the next 8 weeks as all 21 patients on triamcinolone plus placebo were assigned to receive half the dose of triamcinolone 200 g twice daily plus continued placebo (placebo–minus group). Patients on full dose ICS plus salmeterol were randomized to either continue on that same dose (salmeterol–plus group) or to continue on salmeterol with half the dose of ICS 200 g daily (salmeterol–minus group). Last was an 8-week ICS elimination phase. The placebo–minus group (previously on ICS 200 g bid plus placebo salmeterol) were assigned to receive placebo ICS and placebo salmeterol. The salmeterol–minus group (receiving a half dose of ICS plus salmeterol) were changed to placebo ICS plus salmeterol. The salmeterol–plus group (receiving a full dose of ICS plus a full dose of salmeterol) continued on that same dose (active control group). The main outcome measure was timed to asthma treatment failure (specifically defined by parameters of pulmonary function and/or clinical deterioration) in patients receiving salmeterol. Results. Treatment failure occurred in 8.3% of the salmeterol–minus group 8 weeks after ICS treatment was reduced compared with 2.8% of the salmeterol–plus group (active control group, full dose) when the dose of ICS was not changed. Subsequent treatment failure occurred in 46.3% of the salmeterol–minus group 8 weeks after ICS therapy was eliminated compared with 13.7% of the salmeterol–plus group (active control group, full dose). The relative risk of treatment failure at the end of the ICS elimination phase in the salmeterol–minus group (plus placebo ICS) was 4.3% compared with the salmeterol–plus group (active control group, full dose). Secondary outcome measures included a lower mean presalmeterol forced expiratory volume in 1 second (FEV1) in the salmeterol– minus group versus the salmeterol–plus group and decreased salmeterol-protected methacholine response was less in the salmeterol minus versus the salmeterol plus group. Conclusions. In patients with persistent asthma suboptimally controlled by triamcinolone therapy alone, but whose asthma symptoms improve after addition of salmeterol, a 50% reduction in ICS dose can occur without a significant loss of asthma control. However, total elimination of ICS therapy results in a significant deterioration of asthma control as well as decline in pulmonary function and loss of bronchoprotection. Reviewer’s Comments. This study is entirely consistent with the current consensus that although salmeterol may improve asthma control when given along with an inhaled steroid and provide significant steroid-sparing effects. In addition, it supports the notion that salmeterol should not be used as monotherapy for persistent asthma.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Effect of salmeterol on allergen-induced airway inflammation in mild allergic asthma.

A previous study suggested that the long-acting beta2-adrenergic agonist salmeterol (SM) had inhibitory effects on bronchial mucosal inflammation 6 hours after allergen exposure. To further evaluate the influence of SM on allergen-induced airway inflammation. We studied, in a randomized, double-blind, cross-over trial, 16 mild asthmatic patients who had a dual asthmatic response to allergen inh...

متن کامل

5-BDBD ameliorates an OVA-induced allergic asthma by the reduction of Th2 cytokines production

Objective(s): P2X4R is expressed in immunocyte and lung tissues. It has been a focus in inflammatory responses recently. This study investigated whether blockage of P2X4R attenuates allergic inflammation by modulating T cell response in ovalbumin-sensitized mice. Materials and Methods: Ovalbumin was used to sensitize and challenge for a mouse model. Intranasal application of 5-BDBD, P2X4R antag...

متن کامل

Tolerance to the protective effect of salmeterol on allergen challenge can be partially restored by the withdrawal of salmeterol regular treatment.

STUDY OBJECTIVE To assess whether the withdrawal of salmeterol treatment for 3 days (72 h) can restore its bronchoprotective ability on specific bronchial provocative test (sBPT) with allergen, which was completely lost after 1 week of regular treatment with salmeterol. STUDY DESIGN Single-blind design. PATIENTS AND METHODS We investigated 10 nonsmoking subjects (8 men and 2 women; mean +/-...

متن کامل

The effects of bone marrow-derived mesenchymal stem cells on ovalbumin-induced allergic asthma and cytokine responses in mice

Objective(s): Allergic Asthma is an inflammatory disease of the lungs that is characterized by increased infiltration of leukocytes into the airways, limiting the respiratory function. Studies suggest that a defective general regulatory system against inflammation could be a significant factor in allergic asthma. It has been shown that Mesenchymal stem cells (MSCs) have a cellular immunosuppres...

متن کامل

Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma.

BACKGROUND Addition of the long acting beta2 agonist salmeterol to inhaled corticosteroids leads to better symptomatic asthma control than increasing the dose of inhaled corticosteroids. However, little is known about the long term effects of adding salmeterol on the asthmatic inflammatory process, control of which is considered important for the long term outcome of asthma. METHODS After a 4...

متن کامل

Short paper EVect of a single dose of salmeterol on the increase in airway eosinophils induced by allergen challenge in asthmatic subjects

Background—The long acting â2 agonist salmeterol is very eVective in preventing asthmatic responses to specific stimuli, and this eVect could theoretically be due to some anti-inflammatory property in addition to bronchodilator property. Methods—The protective eVect of a single dose of salmeterol (50 μg) on allergen induced early and late responses and on the associated airway inflammation was ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2002